Randomized control trial of immunosuppression in paraquat poisoning [10]

Critical Care Medicine

Volumn 35, Issue 1, 2007, Pages 330-331

  Gunawardena, Gihan ^a   Roberts, Darren M ^a   Buckley, Nick A ^a  

^a The Australian National University   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; PARAQUAT;

CLINICAL TRIAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MORTALITY; NOMOGRAM; PARAQUAT POISONING; PREDICTION; PRIORITY JOURNAL; SAMPLE SIZE; SAMPLING ERROR; SURVIVAL;

CRITICAL CARE; DATA INTERPRETATION, STATISTICAL; GUIDELINES; HERBICIDES; HUMANS; IMMUNOSUPPRESSION; PARAQUAT; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN;

EID: 33845947985     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000251817.82117.7D     Document Type: Letter

References (5)

1. Eddleston M, Wilks MF, Buckley NA: Prospects for treatment of paraquat-induced lung fibrosis with immunosuppressive drugs and the need for better prediction of outcome: A systematic review. Q J Med 2003; 96:809-824
2. Lin JL, Leu ML, Liu YC, et al: A prospective clinical trial of pulse therapy with glucocorticoid and cyclophosphamide in moderate to severe paraquat-poisoned patients. Am J Respir Crit Care Med 1999; 159:357-360
3. Lin JL, Lin-Tan DT, Chen KH, et al: Repeated pulse of methylprednisolone and cyclophosphamide with continuous dexamethasone therapy for patients with severe paraquat poisoning. Crit Care Med 2006; 34:368-373
4. Altman DG, Schulz KF, Moher D, et al: The revised CONSORT statement for reporting randomized trials: Explanation and elaboration. Ann Intern Med 2001; 134:663-694
5. Hart TB, Nevitt A, Whitehead A: A new statistical approach to the prognostic significance of plasma paraquat concentrations. Lancet 1984; 2(8413):1222-1223